The influence of firm and industry characteristics on returns from technology licensing deals: evidence from the US computer and pharmaceutical sectors-Reference-Cited by-同舟云学术

The influence of firm and industry characteristics on returns from technology licensing deals: evidence from the US computer and pharmaceutical sectors

Published:2012-09-27 Issue:5 Volume:42 Page:435-454
ISSN:0033-6807
Container-title:R&D Management
language:en
Short-container-title:R&D Manage

Author:

Walter Jorge¹

Affiliation:

1. Department of Strategic Management and Public Policy; School of Business; The George Washington University; 2201 G Street, NW Funger Hall 615 Washington, DC 20052 USA

Funder

Portland State University

Publisher

Wiley

Subject

Management of Technology and Innovation,Strategy and Management,General Business, Management and Accounting,Business and International Management

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1467-9310.2012.00693.x/fullpdf

Reference113 articles.

1. The intra-alliance division of value created through collaboration;Adegbesan;Strategic Management Journal,2011

2. Do firms learn to create value? The case of alliances;Anand;Strategic Management Journal,2000a

3. The structure of licensing contracts;Anand;Journal of Industrial Economics,2000b

4. Licensing the market for technology;Arora;Journal of Economic Behavior and Organization,2003

5. Markets for Technology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How does technology catch-up experience affect innovation performance of latecomer firms?: Evidence from the Korea pharmaceutical industry;Asian Journal of Technology Innovation;2024-01-31

2. What determines the performance of pharmaceutical firms in India on account of COVID-19 interventions?;International Journal of Pharmaceutical and Healthcare Marketing;2023-12-29

3. Knowledge management capability and outbound open innovation: Unpacking the role of desorptive capacity;Knowledge and Process Management;2023-06-21

4. Latecomer firms’ technological learning strategies for creative imitation: evidence from the Korean pharmaceutical industry;Technology Analysis & Strategic Management;2023-05-25

5. Technology sourcing and the dark side of open innovation: Evidence from the biopharmaceutical sector;Technovation;2023-01